CALL TOLL FREE:
FAX  TOLL  FREE:
1.866.930.3784
5:30 AM - 8:00 PM (M-F)
7:00 AM - 3:30 PM (S/S)

Betamethasone Tablets (Betamethasone)

Type
Product
Manufacturer
Country
Dosage
Qty-Price (USD)
Type: drug type
Product: Betamethasone Tablets
Manufacturer: GSK
Country: India
Dosage: 0.5 mg
Qty-Price:
Type: drug type
Product: Betamethasone Tablets
Manufacturer: GSK
Country: India
Dosage: 1 mg
Qty-Price:

Generic Equivalent of Betamethasone Tablets
Type
Product
Manufacturer
Country
Dosage
Qty-Price (USD)
There is no generic product of Betamethasone Tablets.

Betamethasone Tablets Information

Each tablet contains 500 micrograms (0.5mg) betamethasone as betamethasone sodium phosphate PhEur. Betnelan (Betamethasone) is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone sodium phosphate is very soluble in water, and is therefore less likely to cause local gastric irritation than corticosteroids which are only slightly soluble. This is important when high doses are required, as in immuno-suppressive therapy. Betnesol does not normally cause retention of salt and water and the risk of inducing oedema and hypertension is almost negligible. A wide variety of diseases may sometimes require corticosteroid therapy. Some of the principal indications are: Bronchial asthma, severe hypersensitivity reactions, anaphylaxis, rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (excluding systemic sclerosis), polyarteritis nodosa; Inflammatory skin disorders, including pemphigus vulgaris, bullous pemphigoid and pyoderma gangrenosum; Minimal change nephrotic syndrome, acute interstitial nephritis; Ulcerative colitis, Crohn's disease, sarcoidosis, rheumatic carditis; Haemolytic anaemia (autoimmune), acute and lymphatic leukaemia, malignant lymphoma, multiple myeloma, idiopathic thrombocytopenic purpura; Immunosuppression in transplantation.

Betamethasone Tablets Side Effects

The incidence of predictable undesirable effects, including hypothalamic-pituitary-adrenal (HPA) axis suppression correlates with the relative potency of the drug, dosage, timing of administration and the duration of treatment. (see “Special Warnings and Precautions for Use”) Endocrine/metabolic Suppression of the hypothalamic-pituitary-adrenal axis, growth suppression in infancy, childhood and adolescence, menstrual irregularity and amenorrhoea. Cushingoid facies, hirsutism, weight gain, impaired carbohydrate tolerance with increased requirement for antidiabetic therapy. Negative protein, nitrogen and calcium balance. Increased appetite. Hyperhydrosis. . Increased high –density lipoprotein and low – density lipoprotein concentrations in the blood. Anti-inflammatory and immunosuppressive effects Increased susceptibility to and severity of infections with suppression of clinical symptoms and signs, opportunistic infections, recurrence of dormant tuberculosis (see “Special Warnings and Precautions for Use”). Musculoskeletal Osteoporosis, vertebral and long bone fractures, avascular osteonecrosis, tendon rupture, proximal myopathy. Fluid and electrolyte disturbance Sodium and water retention, hypertension, potassium loss, hypokalaemic alkalosis. Neuropsychiatric Euphoria, psychological dependence, depression, psychosis, insomnia, and aggravation of schizophrenia. Increased intra-cranial pressure with papilloedema in children (pseudotumour cerebri), usually after treatment withdrawal. Aggravation of epilepsy. Ophthalmic Increased intra-ocular pressure, glaucoma, papilloedema, posterior subcapsular cataracts, corneal or scleral thinning, exacerbation of ophthalmic viral or fungal diseases. Cardiac Myocardial rupture following recent myocardial infarction. Gastrointestinal Abdominal distension, oesophageal ulceration, nausea, dyspepsia, peptic ulceration with perforation and haemorrhage, acute pancreatitis, candidiasis. Dermatological Impaired healing, skin atrophy, bruising, telangiectasia, striae, acne. General Hypersensitivity including anaphylaxis, has been reported. Leucocytosis. Thrombo-embolism. Malaise. Hiccups. Withdrawal symptoms and signs Too rapid a reduction of corticosteroid dosage following prolonged treatment can lead to acute adrenal insufficiency, hypotension and death (see “Special Warnings and Precautions for Use”). A 'withdrawal syndrome' may also occur including; fever, myalgia, arthralgia, rhinitis, conjunctivitis, painful itchy skin nodules and loss of weight.

Similar Drugs in the category of Allergy Medication:

   Nasonex Nasal Spray    Omnaris    Rupall    Beconase Hayfever Aq Nasal Spray    Alrex

The information on this page is sourced from independent third parties contracted by CanadaPharmacyOnline. While we cannot guarantee its medical accuracy, we strongly recommend consulting a healthcare professional for personalized advice regarding medications or medical conditions. Prices listed are in US dollars.

Reviews From Real Customers
Drug Categories

Top Products

Prescriptions Dispensed from Canada are Dispensed by Candrug Pharmacy #18985. 202A 8322-130th Street, Surrey, British Columbia, Canada V3W 8J9, 604-543-8711. Pharmacy Manager: Carol Hou.
This pharmacy is duly licensed in the province of British Columbia, Canada by the College of Pharmacists of BC. If you have any questions or concerns you can contact the college at: 200-1765 West 8th Ave Vancouver, BC V6J 5C6 Canada.
© Copyright 2006 - 2024 Canada Pharmacy Online. All Rights Reserved.